Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists for Monday » 16:25
11/22/21
11/22
16:25
11/22/21
16:25
ERIC

Ericsson

$10.13 /

-0.795 (-7.28%)

, VG

Vonage

$20.81 /

+4.44 (+27.12%)

, AVYA

Avaya

$22.00 /

+4.02 (+22.36%)

, TSLA

Tesla

$1,156.86 /

+20.35 (+1.79%)

, WMT

Walmart

$144.77 /

+2.37 (+1.66%)

, TWTR

Twitter

$47.31 /

-1.13 (-2.33%)

, ATVI

Activision Blizzard

$62.20 /

-0.17 (-0.27%)

, GFS

GlobalFoundries

$63.83 /

+1.93 (+3.12%)

, BLNK

Blink Charging

$38.20 /

-4.895 (-11.36%)

, TDOC

Teladoc

$109.10 /

-7.79 (-6.66%)

, XEL

Xcel Energy

$66.29 /

+1.18 (+1.81%)

, MNST

Monster Beverage

$90.09 /

+0.79 (+0.88%)

, AAPL

Apple

$161.12 /

+0.57 (+0.36%)

, MVRS

Meta

/

+

, FB

Facebook; also tag MVRS

$341.17 /

-4.19 (-1.21%)

, BA

Boeing

$209.91 /

-4.11 (-1.92%)

, ASTR

Astra

$11.15 /

+1.625 (+17.06%)

, PRVB

Provention Bio

$7.18 /

+0.925 (+14.80%)

, XPEV

XPeng

$47.40 /

+0.54 (+1.15%)

, RIVN

Rivian Automotive

$118.73 /

-9.91 (-7.70%)

, F

Ford

$20.48 /

+1.09 (+5.62%)

, AUPH

Aurinia Pharmaceuticals

$19.65 /

-8.84 (-31.03%)

, CRNC

Cerence

$82.50 /

-21.42 (-20.61%)

, ELYS

Elys Game Technology

$3.32 /

-0.49 (-12.86%)

, QIPT

Quipt Home Medical

$6.77 /

-0.075 (-1.10%)

, FNA

Paragon 28

$20.59 /

-0.53 (-2.51%)

, TWST

Twist Bioscience

$98.22 /

-12.615 (-11.38%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

XEL Xcel Energy
$66.29 /

+1.18 (+1.81%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

MVRS Meta
/

+

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

GFS GlobalFoundries
$63.83 /

+1.93 (+3.12%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

F Ford
$20.48 /

+1.09 (+5.62%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

CRNC Cerence
$82.50 /

-21.42 (-20.61%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AVYA Avaya
$22.00 /

+4.02 (+22.36%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

ASTR Astra
$11.15 /

+1.625 (+17.06%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

11/23/21 KeyBanc
Vonage downgraded to Sector Weight from Overweight at KeyBanc
10/25/21 BofA
Ericsson reinstated with an Underperform at BofA
10/20/21 JPMorgan
Ericsson price target lowered to SEK 123 from SEK 125 at JPMorgan
10/20/21 Cowen
Ericsson price target lowered to $18 from $21 at Cowen
VG Vonage
$20.81 /

+4.44 (+27.12%)

11/23/21 Baird
Vonage downgraded to Neutral from Outperform at Baird
11/22/21 Craig-Hallum
Vonage downgraded to Hold from Buy at Craig-Hallum
11/22/21 Jefferies
Jefferies raises Vonage price target to $21, sees high odds acquisition closes
AVYA Avaya
$22.00 /

+4.02 (+22.36%)

11/23/21 Citi
Avaya price target raised to $25 from $24 at Citi
11/12/21 Cowen
Avaya price target lowered to $33 from $40 at Cowen
10/20/21 Barclays
Avaya downgraded to Equal Weight from Overweight at Barclays
10/18/21 JPMorgan
Avaya downgraded to Neutral into 'more modest year' at JPMorgan
TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
11/17/21 Exane BNP Paribas
Exane BNP Paribas boosts Tesla target to $780, keeps Underpeform rating
11/15/21 Wedbush
GM stock may hit $100 over next 12-18 months in bull case scenario, says Wedbush
WMT Walmart
$144.77 /

+2.37 (+1.66%)

11/19/21
Fly Intel: Top five analyst upgrades
11/19/21 MKM Partners
MKM upgrades Walmart to Buy with $166 target heading into holidays
11/19/21 MKM Partners
Walmart upgraded to Buy from Neutral at MKM Partners
11/18/21 Credit Suisse
Credit Suisse transfers coverage of Walmart
TWTR Twitter
$47.31 /

-1.13 (-2.33%)

11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/01/21 Citi
Citi upgrades Snap to Neutral, cuts price target to $53
10/28/21 BMO Capital
Twitter price target lowered to $65 from $70 at BMO Capital
10/28/21 Wells Fargo
Twitter price target lowered to $70 from $82 at Wells Fargo
ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

11/22/21
Fly Intel: Top five analyst downgrades
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
11/22/21 Truist
Activision Blizzard price target lowered to $74 from $101 at Truist
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
GFS GlobalFoundries
$63.83 /

+1.93 (+3.12%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

11/22/21 Cowen
Blink Charging downgraded to Market Perform from Outperform at Cowen
11/15/21
Fly Intel: Top five analyst upgrades
11/15/21 DA Davidson
Blink Charging price target raised to $35 from $31 at DA Davidson
TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

11/23/21 Canaccord
Teladoc price target lowered to $160 from $188 at Canaccord
11/22/21 Stifel
Teladoc price target lowered to $135 from $153 at Stifel
11/22/21 BTIG
Teladoc downgraded to Neutral from Buy at BTIG
XEL Xcel Energy
$66.29 /

+1.18 (+1.81%)

11/22/21
Fly Intel: Top five analyst upgrades
11/21/21 BMO Capital
Xcel Energy upgraded to Outperform from Market Perform at BMO Capital
11/02/21 Mizuho
Xcel Energy price target lowered to $64 from $70 at Mizuho
10/29/21 BofA
Xcel Energy upgraded to Buy at BofA following underperformance
MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

11/23/21 Morgan Stanley
Full Monster-Constellation combo 'less plausible' than JV, says Morgan Stanley
11/23/21 Citi
Citi 'highly skeptical' Coke would abandon relationship with Monster
11/22/21 Stifel
Monster-Constellation JV makes sense, merger 'less so,' says Stifel
11/02/21 Deutsche Bank
Monster Beverage price target lowered to $105 from $108 at Deutsche Bank
AAPL Apple
$161.12 /

+0.57 (+0.36%)

11/23/21 Credit Suisse
Matterport price target raised to $34 from $25 at Credit Suisse
11/19/21 Morgan Stanley
Morgan Stanley lays out five points to keep in mind on Apple Car
11/18/21 Piper Sandler
Jamf competitive threat from Apple is minimal, says Piper Sandler
MVRS Meta
/

+

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
BA Boeing
$209.91 /

-4.11 (-1.92%)

11/18/21
Fly Intel: Top five analyst upgrades
11/18/21 JPMorgan
Boeing upgraded to Overweight from Neutral at JPMorgan
11/17/21
Fly Intel: Top five analyst upgrades
11/17/21 Wells Fargo
Wells Fargo upgrades Boeing on positive risk/reward after underperformance
ASTR Astra
$11.15 /

+1.625 (+17.06%)

10/11/21 Deutsche Bank
Astra named short-term investment idea at Deutsche Bank
10/04/21
Fly Intel: Top five analyst initiations
10/04/21 BofA
Astra initiated with an Underperform at BofA
07/27/21 Deutsche Bank
Astra initiated with a Buy at Deutsche Bank
PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

11/23/21 SMBC Nikko
Provention Bio upgraded to Outperform from Neutral at SMBC Nikko
07/09/21 Chardan
Provention Bio coverage transferred at Chardan
05/28/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
05/25/21 SVB Leerink
Provention Bio briefing documents a positive, says SVB Leerink
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

11/11/21 Citi
XPeng price target raised to $87 from $53.40 at Citi
10/28/21
Fly Intel: Top five analyst initiations
10/28/21 Bernstein
Bernstein starts XPeng at Outperform, sees EVs as 'future' of Chinese autos
10/28/21 Bernstein
XPeng initiated with an Outperform at Bernstein
RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

F Ford
$20.48 /

+1.09 (+5.62%)

11/11/21 Morgan Stanley
Morgan Stanley bumps up Ford price target to $12, stays Underweight
11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
11/02/21 Nomura
Ford downgraded to Reduce from Neutral at Nomura
10/29/21 Tigress Financial
Snap-On price target raised to $295 from $289 at Tigress Financial
AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
CRNC Cerence
$82.50 /

-21.42 (-20.61%)

11/23/21 Craig-Hallum
Cerence price target lowered to $135 from $145 at Craig-Hallum
11/23/21 Wedbush
Cerence price target lowered to $115 from $140 at Wedbush
11/23/21 RBC Capital
Cerence price target lowered to $95 from $110 at RBC Capital
10/06/21 RBC Capital
RBC Capital upgraded Cerence to Outperform, sees selloff as overdone
ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

07/26/21 Maxim
Elys Game Technology initiated with a Buy at Maxim
03/10/21
Fly Intel: Top five analyst initiations
03/10/21 H.C. Wainwright
Elys Game Technology initiated with a Buy at H.C. Wainwright
QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

11/19/21 Canaccord
Quipt Home Medical price target raised to C$11 from C$10 at Canaccord
11/17/21 Stifel
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel
10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
FNA Paragon 28
$20.59 /

-0.53 (-2.51%)

11/22/21 Piper Sandler
Paragon 28 a 'name to own' after strong first public report, says Piper Sandler
11/09/21 Canaccord
Canaccord starts foot & ankle share taker Paragon 28 with a Buy
11/09/21 Needham
Paragon 28 initiated with a Buy at Needham
11/09/21 Canaccord
Paragon 28 initiated with a Buy at Canaccord
TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

11/23/21 Baird
Twist Bioscience price target lowered to $113 from $130 at Baird
10/14/21 Cowen
Twist Bioscience coverage transferred at Cowen
08/09/21 Baird
Twist Bioscience price target lowered to $130 from $140 at Baird
06/29/21 William Blair
Twist Bioscience initiated with an Outperform at William Blair
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

XEL Xcel Energy
$66.29 /

+1.18 (+1.81%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

FNA Paragon 28
$20.59 /

-0.53 (-2.51%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

F Ford
$20.48 /

+1.09 (+5.62%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

CRNC Cerence
$82.50 /

-21.42 (-20.61%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AVYA Avaya
$22.00 /

+4.02 (+22.36%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

  • 10
    Nov
  • 28
    Oct
  • 15
    Oct
  • 14
    Jan
  • 08
    Jan
  • 09
    Dec
  • 03
    Dec
XPEV XPeng
$47.40 /

+0.54 (+1.15%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

MVRS Meta
/

+

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

XPEV XPeng
$47.40 /

+0.54 (+1.15%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

VG Vonage
$20.81 /

+4.44 (+27.12%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TWST Twist Bioscience
$98.22 /

-12.615 (-11.38%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

PRVB Provention Bio
$7.18 /

+0.925 (+14.80%)

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

GFS GlobalFoundries
$63.83 /

+1.93 (+3.12%)

FNA Paragon 28
$20.59 /

-0.53 (-2.51%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

CRNC Cerence
$82.50 /

-21.42 (-20.61%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

ASTR Astra
$11.15 /

+1.625 (+17.06%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

XPEV XPeng
$47.40 /

+0.54 (+1.15%)

WMT Walmart
$144.77 /

+2.37 (+1.66%)

TWTR Twitter
$47.31 /

-1.13 (-2.33%)

TSLA Tesla
$1,156.86 /

+20.35 (+1.79%)

TDOC Teladoc
$109.10 /

-7.79 (-6.66%)

RIVN Rivian Automotive
$118.73 /

-9.91 (-7.70%)

QIPT Quipt Home Medical
$6.77 /

-0.075 (-1.10%)

MNST Monster Beverage
$90.09 /

+0.79 (+0.88%)

FB Facebook; also tag MVRS
$341.17 /

-4.19 (-1.21%)

F Ford
$20.48 /

+1.09 (+5.62%)

ERIC Ericsson
$10.13 /

-0.795 (-7.28%)

ELYS Elys Game Technology
$3.32 /

-0.49 (-12.86%)

BLNK Blink Charging
$38.20 /

-4.895 (-11.36%)

BA Boeing
$209.91 /

-4.11 (-1.92%)

AVYA Avaya
$22.00 /

+4.02 (+22.36%)

AUPH Aurinia Pharmaceuticals
$19.65 /

-8.84 (-31.03%)

ATVI Activision Blizzard
$62.20 /

-0.17 (-0.27%)

ASTR Astra
$11.15 /

+1.625 (+17.06%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

AAPL Apple
$161.12 /

+0.57 (+0.36%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:10
11/22/21
11/22
12:10
11/22/21
12:10
VG

Vonage

$20.62 /

+4.25 (+25.96%)

, ERIC

Ericsson

$10.23 /

-0.695 (-6.36%)

, AVYA

Avaya

$21.70 /

+3.72 (+20.69%)

, CRNC

Cerence

$82.95 /

-20.97 (-20.18%)

, TSLA

Tesla

$1,151.58 /

+15.07 (+1.33%)

, MNST

Monster Beverage

$90.25 /

+0.945 (+1.06%)

, STZ

Constellation Brands

$234.69 /

-0.68 (-0.29%)

, STZ.B

Constellation Brands; also tag STZ

$239.26 /

+24.95 (+11.64%)

, ATVI

Activision Blizzard

$60.69 /

-1.68 (-2.69%)

, AAPL

Apple

$163.63 /

+3.075 (+1.92%)

, NFLX

Netflix

$659.68 /

-18.915 (-2.79%)

, MVRS

Meta

/

+

, FB

Facebook; also tag MVRS

$341.07 /

-4.29 (-1.24%)

, ASTR

Astra

$12.11 /

+2.585 (+27.14%)

, PRVB

Provention Bio

$7.26 /

+1.01 (+16.16%)

, XPEV

XPeng

$47.50 /

+0.64 (+1.37%)

, RIVN

Rivian Automotive

$111.43 /

-17.21 (-13.38%)

, F

Ford

$19.90 /

+0.51 (+2.63%)

, AUPH

Aurinia Pharmaceuticals

$20.08 /

-8.41 (-29.52%)

, SR

Spire

$62.47 /

+0.82 (+1.33%)

, ELYS

Elys Game Technology

$3.37 /

-0.44 (-11.55%)

, QIPT

Quipt Home Medical

$6.87 /

+0.03 (+0.44%)

, FNA

Paragon 28

$21.90 /

+0.78 (+3.69%)

, TWST

Twist Bioscience

$100.90 /

-9.935 (-8.96%)

, GFS

GlobalFoundries

$65.00 /

+3.1 (+5.01%)

, BLNK

Blink Charging

$37.94 /

-5.15 (-11.95%)

, TDOC

Teladoc

$108.83 /

-8.06 (-6.90%)

, XEL

Xcel Energy

$66.87 /

+1.76 (+2.70%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

XEL Xcel Energy
$66.87 /

+1.76 (+2.70%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

SR Spire
$62.47 /

+0.82 (+1.33%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MVRS Meta
/

+

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

CRNC Cerence
$82.95 /

-20.97 (-20.18%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AVYA Avaya
$21.70 /

+3.72 (+20.69%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

ASTR Astra
$12.11 /

+2.585 (+27.14%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

11/22/21 William Blair
Vonage downgraded to Market Perform from Outperform at William Blair
11/22/21 Northland
Vonage downgraded to Market Perform from Outperform at Northland
11/22/21 Colliers
Vonage downgraded to Neutral from Buy at Colliers
11/05/21 JPMorgan
Vonage upgraded to Overweight from Neutral at JPMorgan
ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

10/25/21 BofA
Ericsson reinstated with an Underperform at BofA
10/20/21 JPMorgan
Ericsson price target lowered to SEK 123 from SEK 125 at JPMorgan
10/20/21 Cowen
Ericsson price target lowered to $18 from $21 at Cowen
10/08/21 Barclays
Ericsson price target raised to SEK 150 from SEK 145 at Barclays
AVYA Avaya
$21.70 /

+3.72 (+20.69%)

11/12/21 Cowen
Avaya price target lowered to $33 from $40 at Cowen
10/20/21 Barclays
Avaya downgraded to Equal Weight from Overweight at Barclays
10/18/21 JPMorgan
Avaya downgraded to Neutral into 'more modest year' at JPMorgan
10/18/21 JPMorgan
Avaya downgraded to Neutral from Overweight at JPMorgan
CRNC Cerence
$82.95 /

-20.97 (-20.18%)

10/06/21 RBC Capital
RBC Capital upgraded Cerence to Outperform, sees selloff as overdone
10/06/21 RBC Capital
Cerence upgraded to Outperform from Sector Perform at RBC Capital
08/16/21 Evercore ISI
Cerence price target raised to $150 from $125 at Evercore ISI
08/10/21 Baird
Cerence price target raised to $135 from $122 at Baird
TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
11/17/21 Exane BNP Paribas
Exane BNP Paribas boosts Tesla target to $780, keeps Underpeform rating
11/15/21 Wedbush
GM stock may hit $100 over next 12-18 months in bull case scenario, says Wedbush
MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

11/22/21 Stifel
Monster-Constellation JV makes sense, merger 'less so,' says Stifel
11/02/21 Deutsche Bank
Monster Beverage price target lowered to $105 from $108 at Deutsche Bank
11/01/21
Fly Intel: Top five analyst initiations
11/01/21 Redburn
Monster Beverage initiated with a Neutral at Redburn
STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

11/01/21 Cantor Fitzgerald
Tilray downgraded to Neutral from Overweight at Cantor Fitzgerald
10/13/21 HSBC
HSBC upgrades Constellation Brands to Buy on ' strong' fundamentals
10/13/21 HSBC
Constellation Brands upgraded to Buy from Hold at HSBC
STZ.B Constellation Brands; also tag STZ
$239.26 /

+24.95 (+11.64%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

11/22/21
Fly Intel: Top five analyst downgrades
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
11/22/21 Truist
Activision Blizzard price target lowered to $74 from $101 at Truist
11/22/21 MKM Partners
Activision Blizzard downgraded to Sell from Neutral at MKM Partners
AAPL Apple
$163.63 /

+3.075 (+1.92%)

11/19/21 Morgan Stanley
Morgan Stanley lays out five points to keep in mind on Apple Car
11/18/21 Piper Sandler
Jamf competitive threat from Apple is minimal, says Piper Sandler
11/17/21 Bernstein
Apple able to repurchase 3%-4% of shares/year until end of 2026, says Bernstein
NFLX Netflix
$659.68 /

-18.915 (-2.79%)

11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/15/21 KeyBanc
Netflix price target raised to $725 from $690 at KeyBanc
11/15/21 JPMorgan
Netflix entering 'strongest content quarter ever,' says JPMorgan
MVRS Meta
/

+

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
ASTR Astra
$12.11 /

+2.585 (+27.14%)

10/11/21 Deutsche Bank
Astra named short-term investment idea at Deutsche Bank
10/04/21
Fly Intel: Top five analyst initiations
10/04/21 BofA
Astra initiated with an Underperform at BofA
07/27/21 Deutsche Bank
Astra initiated with a Buy at Deutsche Bank
PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

07/09/21 Chardan
Provention Bio coverage transferred at Chardan
05/28/21 Chardan
Provention Bio price target lowered to $22.50 from $35 at Chardan
05/25/21 SVB Leerink
Provention Bio briefing documents a positive, says SVB Leerink
05/07/21 Cantor Fitzgerald
Provention Bio price target lowered to $19 from $25 at Cantor Fitzgerald
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

11/11/21 Citi
XPeng price target raised to $87 from $53.40 at Citi
10/28/21
Fly Intel: Top five analyst initiations
10/28/21 Bernstein
Bernstein starts XPeng at Outperform, sees EVs as 'future' of Chinese autos
10/28/21 Bernstein
XPeng initiated with an Outperform at Bernstein
RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

F Ford
$19.90 /

+0.51 (+2.63%)

11/11/21 Morgan Stanley
Morgan Stanley bumps up Ford price target to $12, stays Underweight
11/02/21 Nomura
Nomura downgrades Ford to Reduce, calls premium valuation 'hard to justify'
11/02/21 Nomura
Ford downgraded to Reduce from Neutral at Nomura
10/29/21 Tigress Financial
Snap-On price target raised to $295 from $289 at Tigress Financial
AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

11/04/21 H.C. Wainwright
Aurinia Pharmaceuticals price target raised to $40 from $35 at H.C. Wainwright
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
10/28/21 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
SR Spire
$62.47 /

+0.82 (+1.33%)

11/19/21 Mizuho
Spire price target lowered to $69 from $73 at Mizuho
11/16/21 JPMorgan
Spire downgraded to Neutral from Overweight at JPMorgan
11/08/21
Fly Intel: Top five analyst downgrades
11/08/21 BofA
Spire downgraded to Neutral from Buy at BofA
ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

07/26/21 Maxim
Elys Game Technology initiated with a Buy at Maxim
03/10/21
Fly Intel: Top five analyst initiations
03/10/21 H.C. Wainwright
Elys Game Technology initiated with a Buy at H.C. Wainwright
QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

11/19/21 Canaccord
Quipt Home Medical price target raised to C$11 from C$10 at Canaccord
11/17/21 Stifel
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel
10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
FNA Paragon 28
$21.90 /

+0.78 (+3.69%)

11/09/21 Canaccord
Canaccord starts foot & ankle share taker Paragon 28 with a Buy
11/09/21 Needham
Paragon 28 initiated with a Buy at Needham
11/09/21 Canaccord
Paragon 28 initiated with a Buy at Canaccord
11/09/21 JMP Securities
Paragon 28 initiated with an Outperform at JMP Securities
TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

10/14/21 Cowen
Twist Bioscience coverage transferred at Cowen
08/09/21 Baird
Twist Bioscience price target lowered to $130 from $140 at Baird
06/29/21 William Blair
Twist Bioscience initiated with an Outperform at William Blair
06/04/21
Fly Intel: Top five analyst initiations
GFS GlobalFoundries
$65.00 /

+3.1 (+5.01%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

11/22/21 Cowen
Blink Charging downgraded to Market Perform from Outperform at Cowen
11/15/21
Fly Intel: Top five analyst upgrades
11/15/21 DA Davidson
Blink Charging price target raised to $35 from $31 at DA Davidson
TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

11/22/21 Stifel
Teladoc price target lowered to $135 from $153 at Stifel
11/22/21 BTIG
Teladoc downgraded to Neutral from Buy at BTIG
11/22/21 BTIG
Teladoc downgraded to Neutral from Buy at BTIG
XEL Xcel Energy
$66.87 /

+1.76 (+2.70%)

11/22/21
Fly Intel: Top five analyst upgrades
11/21/21 BMO Capital
Xcel Energy upgraded to Outperform from Market Perform at BMO Capital
11/02/21 Mizuho
Xcel Energy price target lowered to $64 from $70 at Mizuho
10/29/21 BofA
Xcel Energy upgraded to Buy at BofA following underperformance
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

XEL Xcel Energy
$66.87 /

+1.76 (+2.70%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ.B Constellation Brands; also tag STZ
$239.26 /

+24.95 (+11.64%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

SR Spire
$62.47 /

+0.82 (+1.33%)

QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

FNA Paragon 28
$21.90 /

+0.78 (+3.69%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

CRNC Cerence
$82.95 /

-20.97 (-20.18%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AVYA Avaya
$21.70 /

+3.72 (+20.69%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

  • 10
    Nov
  • 28
    Oct
  • 15
    Oct
  • 14
    Jan
  • 08
    Jan
  • 09
    Dec
  • 03
    Dec
XPEV XPeng
$47.50 /

+0.64 (+1.37%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MVRS Meta
/

+

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

XPEV XPeng
$47.50 /

+0.64 (+1.37%)

VG Vonage
$20.62 /

+4.25 (+25.96%)

TWST Twist Bioscience
$100.90 /

-9.935 (-8.96%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ.B Constellation Brands; also tag STZ
$239.26 /

+24.95 (+11.64%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

PRVB Provention Bio
$7.26 /

+1.01 (+16.16%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MVRS Meta
/

+

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

GFS GlobalFoundries
$65.00 /

+3.1 (+5.01%)

FNA Paragon 28
$21.90 /

+0.78 (+3.69%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

CRNC Cerence
$82.95 /

-20.97 (-20.18%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

ASTR Astra
$12.11 /

+2.585 (+27.14%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

XPEV XPeng
$47.50 /

+0.64 (+1.37%)

TSLA Tesla
$1,151.58 /

+15.07 (+1.33%)

TDOC Teladoc
$108.83 /

-8.06 (-6.90%)

STZ Constellation Brands
$234.69 /

-0.68 (-0.29%)

RIVN Rivian Automotive
$111.43 /

-17.21 (-13.38%)

QIPT Quipt Home Medical
$6.87 /

+0.03 (+0.44%)

NFLX Netflix
$659.68 /

-18.915 (-2.79%)

MNST Monster Beverage
$90.25 /

+0.945 (+1.06%)

FB Facebook; also tag MVRS
$341.07 /

-4.29 (-1.24%)

F Ford
$19.90 /

+0.51 (+2.63%)

ERIC Ericsson
$10.23 /

-0.695 (-6.36%)

ELYS Elys Game Technology
$3.37 /

-0.44 (-11.55%)

BLNK Blink Charging
$37.94 /

-5.15 (-11.95%)

AVYA Avaya
$21.70 /

+3.72 (+20.69%)

AUPH Aurinia Pharmaceuticals
$20.08 /

-8.41 (-29.52%)

ATVI Activision Blizzard
$60.69 /

-1.68 (-2.69%)

ASTR Astra
$12.11 /

+2.585 (+27.14%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

AAPL Apple
$163.63 /

+3.075 (+1.92%)

Earnings
Quipt Home Medical reiterates outlook for calendar end 2022 » 10:58
11/22/21
11/22
10:58
11/22/21
10:58
QIPT

Quipt Home Medical

$6.88 /

+0.04 (+0.58%)

Based on the current…

Based on the current business, market trends and completed and prospective acquisitions, the Company is reiterating the guidance provided on November 16, 2021, for its run-rate revenue for end of calendar 2022 of $180-$190M with $38-$43M in Adjusted EBITDA.

ShowHide Related Items >><<
QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

11/19/21 Canaccord
Quipt Home Medical price target raised to C$11 from C$10 at Canaccord
11/17/21 Stifel
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel
10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

Hot Stocks
Quipt Home Medical enters LOI to acquire respiratory care company » 10:57
11/22/21
11/22
10:57
11/22/21
10:57
QIPT

Quipt Home Medical

$6.88 /

+0.04 (+0.58%)

Quipt Home Medical…

Quipt Home Medical announced that it has executed a non-binding letter of intent dated November 22, 2021 to acquire an arm's length private respiratory care company servicing seven states throughout the U.S. reporting unaudited trailing 12-month annual revenues of approximately $14M, $1M in net income, and positive Adjusted EBITDA. The company said, "The target specializes in providing high-quality, comprehensive respiratory care to patients in the long-term care setting including ventilator management, equipment, oxygen and providing supplies. The target provides these facilities with not only the necessary clinical personnel, but also state-of-the-art respiratory tools and equipment, making it easy for them to care for patients with complex respiratory needs. The target also has a pulmonary rehabilitation service, which assists patients with an even wider variety of respiratory care issues. The target services facilities in seven states throughout the United States, four of which would be new states for Quipt. The target employs 165 remote respiratory therapists which would significantly bolster an already robust Quipt clinical team. With a mission that seeks to improve the patients' health and quality of life by providing outstanding, compassionate respiratory care and unparalleled customer service, this target matches the same passionate mission that Quipt continues to employ. The target represents a new vertical of business for Quipt, which would leverage the Company's highly successful clinical respiratory care platform serving patients in the home, into the long-term care setting. Quipt anticipates purchasing power advantages to bring down the cost of respiratory equipment, and cross selling opportunities to service additional patient needs with complimentary equipment, and supplies. The target would expand Quipt's reach, offerings, and allow for the Company to access more sales touch points, which the Company anticipates will have benefit to its current business." According to the LOI, Quipt expects to close the acquisition for $5,000,000, plus a $500,000 earn out based on certain revenue targets, payable in cash, that would immediately be accretive to Quipt's Adjusted EBITDA and net income. As part of the proposed acquisition the Company would not assume any long-term debt of the target. Closing of the acquisition is subject to final due diligence, final negotiation, and execution of a definitive purchase agreement, all closing conditions being satisfied or waived and all necessary approvals and is expected to occur within the next 90 days. The acquisition would be expected to increase Quipt's annual revenues by approximately $14M and $1M in net income before synergies. Leveraging existing infrastructure, Quipt would expect to achieve additional revenue generated from organic growth, cross selling, and corporate synergies. In Fall of 2021, the Company had initiated steps to increase its $20M credit facility to support the robust pipeline of acquisitions that it was building. The Company is now in the final stages of securing a commitment on increasing the debt facility to $100M. The primary use of this facility is to fund large acquisitions and to support working capital.

ShowHide Related Items >><<
QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

11/19/21 Canaccord
Quipt Home Medical price target raised to C$11 from C$10 at Canaccord
11/17/21 Stifel
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel
10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

QIPT Quipt Home Medical
$6.88 /

+0.04 (+0.58%)

Recommendations
Quipt Home Medical price target raised to C$11 from C$10 at Canaccord » 07:42
11/19/21
11/19
07:42
11/19/21
07:42
QIPT

Quipt Home Medical

$6.67 /

+ (+0.00%)

Canaccord analyst Tania…

Canaccord analyst Tania Gonsalves raised the firm's price target on Quipt Home Medical to C$11 from C$10 and keeps a Buy rating on the shares. The analyst said on the back of M&A pipeline and based on the current business, favorable industry dynamics, and robust acquisition pipeline, the company unveiled new revenue and adjusted EBITDA guidance allowing her to raise her target.

ShowHide Related Items >><<
QIPT Quipt Home Medical
$6.67 /

+ (+0.00%)

QIPT Quipt Home Medical
$6.67 /

+ (+0.00%)

11/17/21 Stifel
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel
10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$6.67 /

+ (+0.00%)

QIPT Quipt Home Medical
$6.67 /

+ (+0.00%)

Recommendations
Quipt Home Medical price target raised to C$12.75 from C$12.40 at Stifel » 11:09
11/17/21
11/17
11:09
11/17/21
11:09
QIPT

Quipt Home Medical

$6.58 /

+0.23 (+3.62%)

Stifel analyst Justin…

Stifel analyst Justin Keywood raised the firm's price target on Quipt Home Medical to C$12.75 from C$12.40 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
QIPT Quipt Home Medical
$6.58 /

+0.23 (+3.62%)

QIPT Quipt Home Medical
$6.58 /

+0.23 (+3.62%)

10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$6.58 /

+0.23 (+3.62%)

QIPT Quipt Home Medical
$6.58 /

+0.23 (+3.62%)

Hot Stocks
Quipt Home Medical acquires biomedical services company for $700,000 in cash » 07:35
11/17/21
11/17
07:35
11/17/21
07:35
QIPT

Quipt Home Medical

$6.35 /

+0.39 (+6.54%)

Quipt Home Medical…

Quipt Home Medical announces that it has recently acquired a privately held biomedical services company, with operations in the Southeastern United States. The acquisition provides Quipt an opportunity to expand into a brand-new service line of biomedical repair services for respiratory equipment including preventative maintenance. Quipt will be able to assist healthcare providers to improve the operational efficiency of their respiratory equipment program. The acquisition services a wide range of respiratory products including ventilators, oxygen devices, CPAP/bilevel devices and more. Quipt will have the opportunity to acquire used equipment and repair in-house. Furthermore, Quipt will penetrate a new sales channel by engaging with customers in this new business unit. Under the terms of the definitive purchase agreement, Quipt acquired the biomedical services operation for approximately $700,000 in cash. "We are delighted to enter this segment of the market, a logical fit for us given the growing number of patients, and referral partners in our network, as well as the burgeoning amount of equipment deliveries we complete every year. Our robust operating engine allows us to synergistically add a new service offering to the platform, which can be rolled out efficiently throughout the entire organization. The opportunity to include annual preventative maintenance and repair services for respiratory equipment is timely and we feel we can penetrate new and existing long term care facilities, hospital systems and other medical facilities with this additional service," said Greg Crawford, Chairman and CEO of Quipt. "We feel this segment can offer additional organic and inorganic growth opportunities and will be very nimble as we work to grow this segment of the business. The end of 2021 is providing Quipt significant momentum across the board and our current pipeline consists of companies reflective of all three tiers of our previously disclosed acquisition strategy and we are very optimistic regarding our opportunity to continue closing targets that fit the strategic vision we have."

ShowHide Related Items >><<
QIPT Quipt Home Medical
$6.35 /

+0.39 (+6.54%)

QIPT Quipt Home Medical
$6.35 /

+0.39 (+6.54%)

10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$6.35 /

+0.39 (+6.54%)

QIPT Quipt Home Medical
$6.35 /

+0.39 (+6.54%)

Hot Stocks
Quipt Home Medical executes LOI to acquire respiratory care company » 07:35
11/16/21
11/16
07:35
11/16/21
07:35
QIPT

Quipt Home Medical

$5.96 /

-0.08 (-1.32%)

Quipt Home Medical…

Quipt Home Medical announces it has executed a non-binding letter of intent, LOI, to acquire an arm's length private respiratory care company in the Midwestern United States reporting unaudited trailing 12-month annual revenues of approximately $13M, $1.6Min net income, and positive Adjusted EBITDA. The target has a heavily weighted respiratory product mix, serving as a leader in the respiratory home care services space for over 25 years in a major metropolitan hub within a Midwestern U.S. state. The target would be expected to increase Quipt's active patient count by over 15,000, which would bring Quipt's total to approximately 170,000 active patients. According to the LOI, Quipt expects to close the acquisition for cash at a reasonable multiple that would immediately be accretive to Quipt's Adjusted EBITDA and net income. As part of the proposed acquisition the Company would not assume any long term debt of the target. Closing of the acquisition is subject to final due diligence, final negotiation and execution of a definitive purchase agreement, all closing conditions being satisfied or waived and all necessary approvals and is expected to occur within the next 60 days. "This is an extremely exciting growth period for Quipt as we see continued acceleration within the existing business and a plethora of strategic acquisition opportunities that we hope will help us scale into attractive markets across the United States," said Greg Crawford, Chairman and CEO of Quipt. "This acquisition target is very powerful as it services a significant metro hub in the Midwest and after closing, we plan on quickly integrating their business operations and leveraging the Company's payor contracts across our existing Midwest locations. We anticipate that this acquisition would be immediately accretive to Quipt's Adjusted EBITDA, overall profitability and would add approximately $13 million to the top-line and $1.6 million in net income. Additionally, we expect to see cross-selling growth from lathering on our clinical ventilation therapy program as an extension to their existing respiratory product mix. We expect to remain very active as we close out 2021 and enter 2022 and look forward to sharing our progress."

ShowHide Related Items >><<
QIPT Quipt Home Medical
$5.96 /

-0.08 (-1.32%)

QIPT Quipt Home Medical
$5.96 /

-0.08 (-1.32%)

10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$5.96 /

-0.08 (-1.32%)

QIPT Quipt Home Medical
$5.96 /

-0.08 (-1.32%)

Conference/Events
Quipt Home Medical participates in a conference call with Benchmark » 04:55
11/10/21
11/10
04:55
11/10/21
04:55
QIPT

Quipt Home Medical

$5.35 /

+0.02 (+0.38%)

Conference call with…

Conference call with management will be held on November 10 at 3 pm hosted by Benchmark.

ShowHide Related Items >><<
QIPT Quipt Home Medical
$5.35 /

+0.02 (+0.38%)

QIPT Quipt Home Medical
$5.35 /

+0.02 (+0.38%)

10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$5.35 /

+0.02 (+0.38%)

QIPT Quipt Home Medical
$5.35 /

+0.02 (+0.38%)

Hot Stocks
Quipt Home Medical announces acquisition of a business in Illinois for $2.5M » 08:45
11/09/21
11/09
08:45
11/09/21
08:45
QIPT

Quipt Home Medical

$5.33 /

+0.14 (+2.70%)

Quipt Home Medical…

Quipt Home Medical announces that it has recently acquired a business with operations in Illinois, reporting unaudited trailing 12-month annual revenues of approximately $2.5M. Post integration, Quipt expects an Adjusted EBITDA for the acquisition target of $0.6M. The acquisition adds a strategic location servicing Central Illinois, a heavily weighted respiratory product mix, and over 3,700 active patients. The business has a diverse payor mix and full suite of products with a focus on respiratory care, representing over 85% of the mix. The acquisition further expands Quipt's operations in Illinois after the Company entered the market in August of 2020 and provides Quipt a coverage sphere between the major markets of St. Louis, Missouri and Chicago, Illinois. Under the terms of the definitive purchase agreement, Quipt acquired the DME operation of the business for approximately $1.7M in cash, and the real estate for $0.5M. It is expected that post integration the acquisition will increase Quipt's annual revenues by approximately $2.5M and Adjusted EBITDA by $0.6M. "Our robust operating engine and proven ability to integrate acquired assets allows us to continue the strong pace of closing strategic acquisitions. Since July we have now completed 6 acquisitions with combined revenues of over $16 million. Combining these newly acquired entities provides us a pathway to scale into new states with each business having a proven track record in the markets they serve and diversified product mixes. In this short period of time, we have amassed infrastructure in 4 new states and further penetrated existing states such as Illinois," said Greg Crawford, Chairman and CEO of Quipt. "Given the favorable regulatory environment, we have been able to accelerate our expansion efforts by economically acquiring smaller respiratory focused home medical providers throughout the United States that fit our stringent acquisition criteria. This newest transaction in Illinois is another example of our strategy to make tuck-in acquisitions to fill in attractive geographies, obtain important insurance contracts, add to our active patient base, and build out our referring physician network. Our current pipeline consists of companies reflective of all three tiers of our previously disclosed acquisition strategy and we are extremely optimistic we will maintain momentum in closing targets that fit the mold."

ShowHide Related Items >><<
QIPT Quipt Home Medical
$5.33 /

+0.14 (+2.70%)

QIPT Quipt Home Medical
$5.33 /

+0.14 (+2.70%)

10/20/21 Benchmark
Quipt Home Medical initiated with a Buy at Benchmark
QIPT Quipt Home Medical
$5.33 /

+0.14 (+2.70%)

QIPT Quipt Home Medical
$5.33 /

+0.14 (+2.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.